Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Immunology and Cancer Research: Kotler Moshe


Last updated December 2021 -  Immunology and Cancer Research

List of Publications

(1) Botvinnik A, Shivam P, Smith Y, Sharma G, Olshevsky U, Moshel O, et al. APOBEC3G rescues cells from the deleterious effects of DNA damage. FEBS J 2021;288(20):6063-6077.

(2) Ramanathan A, Weintraub M, Orlovetskie N, Serruya R, Mani D, Marcu O, et al. A mutation in POLR3E impairs antiviral immune response and RNA polymerase III. Proc Natl Acad Sci U S A 2020;117(36):22113-22121.

(3) Nassar T, Rohald A, Naraykin N, Barasch D, Amsalem O, Prabhu P, et al. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug. J Drug Targeting 2019;27(5-6):590-600.

(4) Bergmann SM, Wang Q, Zeng W, Li Y, Wang Y, Matras M, et al. Validation of a KHV antibody enzyme-linked immunosorbent assay (ELISA). J Fish Dis 2017;40(11):1511-1527.

(5) Galilee M, Britan-Rosich E, Griner SL, Uysal S, Baumgärtel V, Lamb DC, et al. The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical. Structure 2016;24(11):1936-1946.

(6) Prabhu P, Shandilya SMD, Britan-Rosich E, Nagler A, Schiffer CA, Kotler M. Inhibition of APOBEC3G activity impedes double-stranded DNA repair. FEBS J 2016;283(1):112-129.

(7) Fanous J, Swed A, Joubran S, Hurevich M, Britan-Rosich E, Kotler M, et al. Superiority of the S,S conformation in diverse pharmacological processes: Intestinal transport and entry inhibition activity of novel anti-HIV drug lead. Int J Pharm 2015;495(2):660-663.

(8) Morick D, Faigenbaum O, Smirnov M, Fellig Y, Inbal A, Kotler M. Mortality caused by bath exposure of zebrafish (Danio rerio) larvae to nervous necrosis virus is limited to the fourth day postfertilization. Appl Environ Microbiol 2015;81(10):3280-3287.

(9) Nowarski R, Prabhu P, Kenig E, Smith Y, Britan-Rosich E, Kotler M. APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element. J Mol Biol 2014;426(15):2840-2853.

(10) Dishon A, Ashoulin O, Weber ES, Kotler M. Vaccination against Koi Herpesvirus Disease. Fish Vaccination; 2014. p. 321-333.

(11) Shimoni M, Herschhorn A, Britan-Rosich Y, Kotler M, Benhar I, Hizi A. The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV. Viral Immunol 2013;26(4):277-290.

(12) Nowarski R, Kotler M. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res 2013;73(12):3494-3498.

(13) Reingewertz TH, Britan-Rosich E, Rotem-Bamberger S, Viard M, Jacobs A, Miller A, et al. Mapping the Vif-A3G interaction using peptide arrays: A basis for anti-HIV lead peptides. Bioorg Med Chem 2013;21(12):3523-3532.

(14) Ilouze M, Dishon A, Kotler M. Down-regulation of the cyprinid herpesvirus-3 annotated genes in cultured cells maintained at restrictive high temperature. Virus Res 2012;169(1):289-295.

(15) Ilouze M, Dishon A, Kotler M. Coordinated and sequential transcription of the cyprinid herpesvirus-3 annotated genes. Virus Res 2012;169(1):98-106.

(16) Nowarski R, Wilner OI, Cheshin O, Shahar OD, Kenig E, Baraz L, et al. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood 2012;120(2):366-375.

(17) Hanson L, Dishon A, Kotler M. Herpesviruses that infect fish. Viruses 2011;3(11):2160-2191.

(18) Ilouze M, Davidovich M, Diamant A, Kotler M, Dishon A. The outbreak of carp disease caused by CyHV-3 as a model for new emerging viral diseases in aquaculture: A review. Ecol Res 2011;26(5):885-892.

(19) Britan-Rosich E, Nowarski R, Kotler M. Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. J Mol Biol 2011;410(5):1065-1076.

(20) Hurevich M, Swed A, Joubran S, Cohen S, Freeman NS, Britan-Rosich E, et al. Rational conversion of noncontinuous active region in proteins into a small orally bioavailable macrocyclic drug-like molecule: The HIV-1 CD4:gp120 paradigm. Bioorg Med Chem 2010;18(15):5754-5761.

(21) Cadima-Couto I, Freitas-Vieira A, Nowarski R, Britan-Rosich E, Kotler M, Goncalves J. Ubiquitin-fusion as a strategy to modulate protein half-life: A3G antiviral activity revisited. Virology 2009;393(2):286-294.

(22) Harjes E, Gross PJ, Chen K-, Lu Y, Shindo K, Nowarski R, et al. An Extended Structure of the APOBEC3G Catalytic Domain Suggests a Unique Holoenzyme Model. J Mol Biol 2009;389(5):819-832.

(23) Nowarski R, Britan-Rosich E, Kotler M. Reply to "mechanisms of APOBEC3G-catalyzed processive deamination of deoxycytidine on single-stranded DNA". Nat Struct Mol Biol 2009;16(5):455-456.

(24) Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, et al. Unsung hero Robert C. Gallo. Science 2009;323(5911):206-207.

(25) Freeman R, Gill R, Shweky I, Kotler M, Banin U, Willner I. Biosensing and probing of intracellular metabolic pathways by NADH-sensitive quantum dots. Angew Chem Int Ed 2009;48(2):309-313.

(26) Gabizon R, Mor M, Rosenberg MM, Britan L, Hayouka Z, Kotler M, et al. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat. Biopolym Pept Sci Sect 2008;90(2):105-116.

(27) Nowarski R, Britan-Rosich E, Shiloach T, Kotler M. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat Struct Mol Biol 2008;15(10):1059-1066.

(28) Perelberg A, Ilouze M, Kotler M, Steinitz M. Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3). Vaccine 2008;26(29-30):3750-3756.

(29) Davidovich M, Dishon A, Ilouze M, Kotler M. Susceptibility of cyprinid cultured cells to cyprinid herpesvirus 3. Arch Virol 2007;152(8):1541-1546.

(30) Rosenbluh J, Hayouka Z, Loya S, Levin A, Armon-Omer A, Britan E, et al. Interaction between HIV-1 Rev and integrase proteins: A basis for the development of anti-HIV peptides. J Biol Chem 2007;282(21):15743-15753.

(31) Hayouka Z, Rosenbluh J, Levin A, Loya S, Lebendiker M, Veprintsev D, et al. Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A 2007;104(20):8316-8321.

(32) Dishon A, Davidovich M, Ilouze M, Kotler M. Persistence of cyprinid herpesvirus 3 in infected cultured carp cells. J Virol 2007;81(9):4828-4836.

(33) Shlyahovsky B, Li D, Weizmann Y, Nowarski R, Kotler M, Willner I. Spotlighting of cocaine by an autonomous aptamer-based machine. J Am Chem Soc 2007;129(13):3814-3815.

(34) Weizmann Y, Beissenhirtz MK, Cheglakov Z, Nowarski R, Kotler M, Willner I. A virus spotlighted by an autonomous DNA machine. Angew Chem Int Ed 2006;45(44):7384-7388.

(35) Ilouze M, Dishon A, Kotler M. Erratum: Characterization of a novel virus causing a lethal disease in Carp and Koi (Microbiology and Molecular Biology Reviews (2006) 70, 1 (147-156)). Microbiol Mol Biol Rev 2006;70(3):857.

(36) Ilouze M, Dishon A, Kahan T, Kotler M. Cyprinid herpes virus-3 (CyHV-3) bears genes of genetically distant large DNA viruses. FEBS Lett 2006;580(18):4473-4478.

(37) Ilouze M, Dishon A, Kotler M. Characterization of a novel virus causing a lethal disease in carp and koi. Microbiol Mol Biol Rev 2006;70(1):147-156.

(38) Dishon A, Perelberg A, Bishara-Shieban J, Ilouze M, Davidovich M, Werker S, et al. Detection of carp interstitial nephritis and gill necrosis virus in fish droppings. Appl Environ Microbiol 2005;71(11):7285-7291.

(39) Perelberg A, Ronen A, Hutoran M, Smith Y, Kotler M. Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccine. Vaccine 2005;23(26):3396-3403.

(40) Shapira Y, Magen Y, Zak T, Kotler M, Hulata G, Levavi-Sivan B. Differential resistance to koi herpes virus (KHV)/carp interstitial nephritis and gill necrosis virus (CNGV) among common carp (Cyprinus carpio L.) strains and crossbreds. Aquaculture 2005;245(1-4):1-11.

(41) Hutoran M, Ronen A, Perelberg A, Ilouze M, Dishon A, Bejerano I, et al. Description of an as yet unclassified DNA virus from diseased Cyprinus carpio species. J Virol 2005;79(4):1983-1991.

(42) Hutoran M, Britan E, Baraz L, Blumenzweig I, Steinitz M, Kotler M. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease. Virology 2004;330(1):261-270.

(43) Pavlov V, Willner I, Dishon A, Kotler M. Amplified detection of telomerase activity using electrochemical and quartz crystal microbalance measurements. Biosens Bioelectron 2004;20(5):1011-1021.

(44) Pikarsky E, Ronen A, Abramowitz J, Levavi-Sivan B, Hutoran M, Shapira Y, et al. Pathogenesis of acute viral disease induced in fish by carp interstitial nephritis and gill necrosis virus. J Virol 2004;78(17):9544-9551.

(45) Alfonta L, Blumenzweig I, Zayats M, Baraz L, Kotler M, Willner I. Electronic transduction of HIV-1 drug resistance in AIDS patients. ChemBioChem 2004;5(7):949-957.

(46) Xiao Y, Pavlov V, Niazov T, Dishon A, Kotler M, Willner I. Catalytic beacons for the detection of DNA and telomerase activity. J Am Chem Soc 2004;126(24):7430-7431.

(47) Pavlov V, Xiao Y, Gill R, Dishon A, Kotler M, Willner I. Amplified Chemiluminescence Surface Detection of DNA and Telomerase Activity Using Catalytic Nucleic Acid Labels. Anal Chem 2004;76(7):2152-2156.

(48) Baraz L, Kotler M. The Vif of human immunodeficiency virus type 1 (HIV-1): Enigmas and solutions. Curr Med Chem 2004;11(2):221-231.

(49) Ronen A, Perelberg A, Abramowitz J, Hutoran M, Tinman S, Bejerano I, et al. Efficient vaccine against the virus causing a lethal disease in cultured Cyprinus carpio. Vaccine 2003;21(32):4677-4684.

(50) Perelberg A, Smirnov M, Hutoran M, Diamant A, Bererano Y, Kotler M. Epidemiological description of a new viral disease afflicting cultured Cyprinus carpio in Israel. Isr J Aquacult Bamidgeh 2003;55(1):5-12.

(51) Lechtzier V, Hutoran M, Levy T, Kotler M, Brenner T, Steinitz M. Sodium dodecyl sulphate-treated proteins as ligands in ELISA. J Immunol Methods 2002;270(1):19-26.

(52) Baraz L, Hutoran M, Blumenzweig I, Katzenellenbogen M, Friedler A, Gilon C, et al. Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region. J Gen Virol 2002;83(9):2225-2230.

(53) Blumenzweig I, Baraz L, Steinitz M, Kotler M, Friedler A, Gilon C, et al. HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases. Biochem Biophys Res Commun 2002;292(4):832-840.

(54) Patolsky F, Lichtenstein A, Kotler M, Willner I. Electronic transduction of polymerase or reverse transcriptase induced replication processes on surfaces: Highly sensitive and specific detection of viral genomes. Angew Chem Int Ed 2001;40(12):2261-2265.

(55) Chen N, Morag A, Almog N, Blumenzweig I, Dreazin O, Kotler M. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. J Gen Virol 2001;82(3):581-590.

(56) Friedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C. Peptides derived from HIV-1 Vif: A non-substrate based novel type of HIV-1 protease inhibitors. J Mol Biol 1999;287(1):93-101.

(57) Baraz L, Khazanov E, Condiotti R, Kotler M, Nagler A. Natural killer (NK) cells prevent virus production in cell culture. Bone Marrow Transplant 1999;24(2):179-189.

(58) Baraz L, Kotler M, Condiotti R, Nagler A. Sensitization of resting T cells to autologous natural-killer-cell- mediated lysis by phytohemagglutinin. Cancer Immunol Immunother 1999;48(9):507-516.

(59) Baraz L, Friedler A, Blumenzweig I, Nussinuv O, Chen N, Steinitz M, et al. Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production. FEBS Lett 1998;441(3):419-426.

(60) Cherry E, Liang C, Rong L, Quan Y, Inouye P, Li X, et al. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins. J Mol Biol 1998;284(1):43-56.

(61) Friedler A, Zakai N, Karni O, Broder YC, Baraz L, Kotler M, et al. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells. Biochemistry 1998;37(16):5616-5622.

(62) Kotler M, Simm M, Zhao YS, Sova P, Chao W, Ohnona S-, et al. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro. J Virol 1997;71(8):5774-5781.

(63) Almog N, Roller R, Arad G, Passi-Even L, Wainberg MA, Kotler M. A p6(Pol)-protease fusion protein is present in mature particles of human immunodeficiency virus type 1. J Virol 1996;70(10):7228-7232.

(64) Arad G, Bar-Meir R, Almog N, Chorev M, Kotler M. Avian Sarcoma Leukemia Virus Protease Linked to the AdjacentGagPolyprotein Is Enzymatically Active. Virology 1995;214(2):439-444.

(65) Arad G, Bar-Meir R, Kotler M. Ribosomal frameshifting at the Gag-Pol junction in avian leukemia sarcoma virus forms a novel cleavage site. FEBS Lett 1995;364(1):1-4.

(66) Avni O, Yefenof E, Kotler M. Clonal dominance of RadLV-induced lymphomas. Leuk Res 1995;19(12):971-976.

(67) Arad G, Chorev M, Shtorch A, Goldblum A, Kotler M. Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production. J Gen Virol 1995;76(8):1917-1925.

(68) Yefenof E, Kotler M. Radiation leukemia virus-induced leukemogenesis: A paradigm of preleukemia and its control by preventive therapy. ADV CANCER RES 1995;66:293-312.

(69) Kotler M, Ruchlemer R, Avni O, Yefenof E. Radiation leukemogenesis: Quantitative relationship between pre‐leukemic cells in the thymus and lymphoma induction. Int J Cancer 1994;56(5):761-765.

(70) Kotler M, Arad G, Hughes SH. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active. J Virol 1992;66(11):6781-6783.

(71) Burstein H, Bizub D, Kotler M, Schatz G, Vogt VM, Skalka AM. Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site. J Virol 1992;66(3):1781-1785.

(72) Yefenof E, Ela C, Kotler M, Vitetta ES. Induction of IL‐4 secretion by the radiation leukemia virus (RadLV): Role in autocrine growth stimulation of RadLV infected pre‐leukemic cells. Int J Cancer 1992;50(3):481-485.

(73) Yefenof E, Epszteyn S, Kotler M. Quantitation, in Vitro Propagation, and Characterization of Preleukemic Cells Induced by Radiation Leukemia Virus. Cancer Res 1991;51(8):2179-2184.

(74) Rayan A, Fliess A, Kotler M, Chorev M, Goldblum A. Theoretical models of aspartic proteases: Active site properties, dimer stability and interactions with model inhibitors. ADV EXP MED BIOL 1991;306:555-558.

(75) Rabia SA, Fibach E, Kotler M, Gatt S. Inactivation of vesicular stomatitis virus by photosensitization following incubation with a pyrene-fatty acid. FEBS Lett 1990;270(1-2):9-10.

(76) Soffer D, Resnick-Roguel N, Eldor A, Kotler M. Multifocal Vascular Tumors in Fowl Induced by a Newly Isolated Retrovirus. Cancer Res 1990;50(15):4787-4793.

(77) Gatt S, Dinur T, Abou-Rabia S, Kotler M, Fibach E. Photosensitization of cultured cells and viruses by pyrene lipids. Indian J Biochem Biophys 1990;27(6):359-362.

(78) Resnick-Roguel N, Eldor A, Burstein H, Hy-Am E, Vlodavsky I, Pane A, et al. Envelope glycoprotein of avian hemangioma retrovirus induces a thrombogenic surface on human and bovine endothelial cells. J Virol 1990;64(8):4029-4032.

(79) Burstein H, Nitzan R-, Hamburger J, Arad G, Malkinson M, Kotler M. Unique sequences in the env gene of avian hemangioma retrovirus are responsible for cytotoxicity and endothelial cell perturbation. Virology 1990;179(1):512-516.

(80) Kotler M, Danho W, Katz RA, Leis J, Skalka AM. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. J Biol Chem 1989;264(6):3428-3435.

(81) Resnick-Roguel N, Burstein H, Hamburger J, Panet A, Eldor A, Vlodavsky I, et al. Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol 1989;63(10):4325-4330.

(82) Yefenof E, Ben-David Y, Kotler M. Preleukemic cells induced by RadLV are of an oligoclonal nature. Leukemia 1988;2(12 SUPPL.):97s-101s.

(83) Katz RA, Kotler M, Skalka AM. cis-Acting intron mutations that affect the efficiency of avian retroviral RNA splicing: Implication for mechanisms of control. J Virol 1988;62(8):2686-2695.

(84) Kotler M, Katz RA, Skalka AM. Activity of avian retroviral protease expressed in Escherichia coli. J Virol 1988;62(8):2696-2700.

(85) Kotler M, Katz RA, Danho W, Leis J, Skalka AM. Synthetic peptides as substrates and inhibitors of a retroviral protease. Proc Natl Acad Sci U S A 1988;85(12):4185-4189.

(86) Roguel N, Moskowitz H, Relevy H, Hamburger J, Kotler M. The methylation state of the proviruses in avian sarcoma virus transformed chick and rat cells. Biochim Biophys Acta Gene Struct Expr 1987;910(2):116-122.

(87) Roguel N, Relevi H, Hamburger J, Kotler M. Genetic alterations of integrated avian sarcoma virus DNA sequences in transformed rat cells. Biochim Biophys Acta Gene Struct Expr 1987;908(1):12-20.

(88) Ben-David Y, Kotler M. Clonal Analysis of Radiation Leukemia Virus-induced Leukemic and Preleukemic Murine Cells. Cancer Res 1987;47:6590-6594.

(89) David YB, Kotler M, Yefenof E. A highly leukemogenic radiation leukemia virus isolate is a thymotropic, immunosuppressive retrovirus with a unique rna structure. Int J Cancer 1987;39(4):492-497.

(90) Reuveny S, Corett R, Freeman A, Kotler M, Mizrahi A. Newly developed microcarrier culturing systems--an overview. Dev Biol Stand 1985;60:243-253.

(91) Kotler M, Reuveny S, Mizrahi A, Shahar A. Ion exchange capacity of DEAE microcarriers determined the growth pattern of cells in culture. Dev Biol Stand 1985;60:255-261.

(92) Kotler M, Salmon S, Olshevsky U. Acquisition of host cell genetic information by avian sarcoma virus rescued from rat cells transformed by B77 virus. Arch Virol 1984;80(4):249-264.

(93) Burstein H, Kotler M. Viral aetiology of haemangiosarcoma outbreaks among layer hens. Avian Pathol 1984;13(4):715-726.

(94) Kotler M, Rosenberg J, Fridlender B. RNAase-sensitive DNA-dependent DNA polymerase from rat cells transformed by avian sarcoma virus. Biochim Biophys Acta Gene Struct Expr 1984;781(1-2):92-99.

(95) Yefenof E, David YB, Kotler M. High‐ and low‐leukemogenic variants of the radiation leukemia virus (RadLV): Immunogenic, suppressive and genetic properties in relation to leukemogenic activity. Int J Cancer 1984;34(6):875-882.

(96) Lorch Y, Kotler M, Friedmann A. Persistent and acute central nervous system infections are caused by Theiler's murine encephalomyelitis viruses which differ in RNA composition but code for only slightly different proteins. J Virol 1984;52(3):960-965.

(97) Reuveny S, Mizrahi A, Shahar A, Kotler M. Role of substrata in determining the growth topology of transformed and nontransformed cells in culture. Cell Biol Int Rep 1984;8(7):539-549.

(98) Morecki S, Slavin S, Weiss L, Weigensberg M, Friedman A, Kotler M. Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1). Leuk Res 1984;8(5):821-825,827-832.

(99) Reuveny S, Mizrahi A, Kotler M, Freeman A. Mammalian cell propagation on derivatized polyacrylamide microcarriers. Dev Biol Stand 1983;55:11-23.

(100) REUVENY S, MIZRAHI A, KOTLER M, FREEMAN A. New Microcarriers for Culturing Mammalian Cells. Ann New York Acad Sci 1983;413(1):413-415.

(101) Reuveny S, Mizrahi A, Kotler M, Freeman A. Factors effecting cell attachment, spreading, and growth on derivatized microcarriers: II introduction of hydrophobic elements. Biotechnol Bioeng 1983;25(12):2969-2980.

(102) Reuveny S, Mizrahi A, Kotler M, Freeman A. Factors affecting cell attachment, spreading, and growth on derivatized microcarriers. I. Establishment of working system and effect of the type of the amino‐charged groups. Biotechnol Bioeng 1983;25(2):469-480.

(103) Lorch Y, Kotler M, Friedmann A. GDVII and DA isolates of Theiler's virus: Proteins attached to the 5' end of the RNA are bound covalently to the same nucleotides. J Virol 1983;45(3):1150-1154.

(104) Shahar A, Reuveny S, Amir A, Kotler M, Mizrahi A. Synaptogenesis and myelination in dissociated cerebral microcarrier cell cultures. J Neurosci Res 1983;9(3):339-348.

(105) Lorch Y, Friedmann A, Lipton HL, Kotler M. Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol 1981;40(2):560-567.

(106) Kotler M, Balabanova H, Friedmann A, Becker Y. Retrovirus-like particles in EBV-negative burkitt’s lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and down’s syndrome. Br J Cancer 1979;39(4):414-421.

(107) Kotler M, Lerer I, Moyal ZB, Spira G. Simultaneous production of mouse endogenous virus and Rous sarcoma virus by Schmidt-Ruppin virus infected mouse cells. J Gen Virol 1978;40(1):141-150.

(108) Kotler M, Balabanova H, Ben-Moyal Z, Friedman A, Becker Y. Properties of the oncornavirus particles isolated from P3HR-1 and Raji human lymphoblastoid cell lines. Isr J Med Sci 1977;13(7):740-746.

(109) Kotler M, Balabanova H, Weinberg E, Friedmann A, Becker Y. Oncornavirus like particles released from arginine deprived human lymphoblastoid cell lines. Proc Natl Acad Sci U S A 1975;72(11):4592-4596.

(110) Lerer I, Kotler M. Proceedings: Interaction of avian sarcoma viruses with mammalian cells. Isr J Med Sci 1975;11(11):1210.

(111) Balabanova H, Kotler M, Becker Y. Transformation of cultured human embryonic fibroblasts by oncornavirus like particles released from a human carcinoma cell line. Proc Natl Acad Sci U S A 1975;72(7):2794-2798.

(112) Kotler M, Haspel O, Becker Y. dsDNA made by RNase-sensitive DNA polymerase from RSV-transformed cells. Nature 1974;249(5456):441-445.

(113) Becker Y, Shlomai J, Asher Y, Weinberg E, Cohen Y, Olshevsky U, et al. Interaction of herpes simplex virus type 1 with rous sarcoma virus-transformed rat cells [XC and r(B77) cell lines]. Intervirology 1974;4(6):325-332.

(114) Becker Y, Balabanova G, Weinberg E, Kotler M. Induction of C-type particles in mammalian cancer cells. Adv Exp Med Biol 1974;44(1):309-327.

(115) Kotler M, Weinberg E, Haspel O, Olshevsky U, Becker Y. Particles released from arginine deprived human leukaemic cells. Nat New Biology 1973;244(137):197-200.

(116) Kotler M, Becker Y. Effect of distamycin A and congocidine on DNA synthesis by rous sarcoma virus reverse transcriptase. FEBS Lett 1972;22(2):222-226.

(117) Kotler M, Weinberg E, Haspel O, Becker Y. Reverse transcriptase-containing particles induced in rous sarcoma virus-transformed rat cells by arginine deprivation. J Virol 1972;10(3):439-446.

(118) Kotler M, Becker Y. Rifampicin and distamycin a as inhibitors of rous sarcoma virus reverse transcriptase. Nat New Biology 1971;234(50):212-214.

(119) Kotler M, Becker Y. The effect of rifampicin and distamycin A on DNA synthesis by RNA-dependent DNA polymerases of Rous sarcoma virus. Harefuah 1971;81(9):412-416.

(120) Kotler M. Interactions of avian sarcoma virus with rat embryo cells in cell culture. J Gen Virol 1971;12(3):199-206.

(121) Kotler M. Control of multiplication of uninfected mouse embryo fibroblasts and mouse embryo fibroblasts converted by infection with murine sarcoma virus (Harvey). Cancer Res 1970;30(10):2493-2496.